Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 12/2016

Open Access 20.06.2016 | Otology

CT findings of the temporal bone in CHARGE syndrome: aspects of importance in cochlear implant surgery

verfasst von: A. C. Vesseur, B. M. Verbist, H. E. Westerlaan, F. J. J. Kloostra, R. J. C. Admiraal, C. M. A. van Ravenswaaij-Arts, R. H. Free, E. A. M. Mylanus

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2016

Abstract

To provide an overview of anomalies of the temporal bone in CHARGE syndrome relevant to cochlear implantation (CI), anatomical structures of the temporal bone and the respective genotypes were analysed. In this retrospective study, 42 CTs of the temporal bone of 42 patients with CHARGE syndrome were reviewed in consensus by two head-and-neck radiologists and two otological surgeons. Anatomical structures of the temporal bone were evaluated and correlated with genetic data. Abnormalities that might affect CI surgery were seen, such as a vascular structure, a petrosquamosal sinus (13 %), an underdeveloped mastoid (8 %) and an aberrant course of the facial nerve crossing the round window (9 %) and/or the promontory (18 %). The appearance of the inner ear varied widely: in 77 % of patients all semicircular canals were absent and the cochlea varied from normal to hypoplastic. A stenotic cochlear aperture was observed in 37 %. The middle ear was often affected with a stenotic round (14 %) or oval window (71 %). More anomalies were observed in patients with truncating mutations than with non-truncating mutations. Temporal bone findings in CHARGE syndrome vary widely. Vascular variants, aberrant route of the facial nerve, an underdeveloped mastoid, aplasia of the semicircular canals, and stenotic round window may complicate cochlear implantation.

Introduction

The criteria for the clinical diagnosis of CHARGE syndrome (MIM, Mendelian Inheritance in Man, 214800), have been defined by Blake et al. and Verloes [1, 2]. CHARGE syndrome is an acronym of Coloboma, Heart disease, choanal Atresia, Retardation, Genital hypoplasia, and Ear anomalies. Organ involvement and severity is highly variable amongst affected patients. A major criterion includes the condition of the temporal bone, which may be hypoplastic or show an absence of the semicircular canals, according to Verloes. Anomalies are seen in the external, middle and inner ear, such as the typically low-set, cup-shaped ears, ossicular malformations, an aberrant course of the facial nerve, hypoplastic internal auditory canal, and an abnormally developed cochlea. Some of these malformations can cause hearing loss: 60–90 % of patients with CHARGE syndrome have moderate to severe hearing loss due to conductive, sensorineural or mixed defects. In most patients, hearing loss can be partially compensated with hearing aids. When hearing aids do not have the desired outcome due to the presence of profound to severe hearing loss, cochlear implantation may be considered. If cognitive disabilities, developmental and behavioural problems do not preclude cochlear implantation, a thorough assessment of the temporal bone anatomy is necessary. Anatomical alterations pose additional surgical risks during the implantation, by hampering the surgical approach to the cochlea or the insertion of the electrode array into the cochlea, and they may influence the surgical results in terms of speech perception.
In 2004, the causative gene for CHARGE syndrome was identified as CHD7 on chromosome 8q12.1 [3]. Since then, 528 different mutations of the gene have been described, but no clear genotype-phenotype correlation could be recognized (www.​CHD7.​org) [4]. In the CHD7 mutation positive patients, the most common clinical findings were temporal bone anomalies (98 %), external ear malformations (91 %), and hearing loss (89 %) [5].
The main goal of this retrospective study was to analyse the presence of the anomalies of the temporal bone and the cochlear nerve in patients with CHARGE syndrome and their potential impact on cochlear implant surgery planning. The secondary goal was to study possible genotype-phenotype correlations.

Materials and methods

We collected analogue and digital CT studies of the temporal bone of patients attending the Dutch CHARGE center of expertise (University Medical Center Groningen, the Netherlands), after obtaining written informed consent from all patients or their legal representatives.
All patients had molecularly confirmed CHARGE syndrome, or clinically typical CHARGE syndrome according to the Blake or Verloes criteria (Tables 1, 4) except for one patient with atypical CHARGE syndrome (patient 12), because the parents did not wish further investigation [1, 2].
Table 1
Characteristics of CHARGE syndrome
a. Major and minor signs of CHARGE syndrome [2]
 Major signs
  Coloboma (iris or choroid, with or without microphthalmia)
  Atresia of choanae
  Hypoplastic semicircular canals
 Minor signs
  Rhombencephalic dysfunction (brainstem dysfunctions, cranial nerve VII to XII palsies and neurosensory deafness)
  Hypothalamo-hypophyseal dysfunction (including GH and gonadotrophin deficiencies)
  Abnormal middle or external ear
  Malformation of mediastinal organs (heart, oesophagus)
  Intellectual disability
b. Definition of typical, atypical, and partial CHARGE syndrome [2]
 Typical CHARGE syndrome
  3 major signs
  2/3 major signs + 2/5 minor signs
 Partial/incomplete CHARGE
  2/3 major  signs + 1/5 minor signs
 Atypical CHARGE
  2/3 major  signs +  0/5 minor signs
  1/3 major signs +  3/5 minors signs
Table 2
Ear structure observations
Structure on CT
Normal
Abnormal
UTI
Pneumatisation mastoid
Good
No cells
UTI
 
73 (87 %)
7 (8 %)
4 (5 %)
Middle ear cavity size
Normal
Small/large
UTI
 
84 (100 %)
0
0
Jugular bulb
Normal
High
UTI
 
59 (70 %)
23 (27 %)
2 (2 %)
Emissary veins
Total
>1 mm
PSS
 
28 (33 %)
25 (30 %)
11 (13 %)
Windows
Present
Absent/stenotic
UTI
 Oval
22 (26 %)
60 (71 %)
2 (2 %)
 Round
70 (83 %)
12 (14 %)
2 (2 %)
Ossicles
Normal
Dysplastic
UTI
 Malleus
83 (99 %)
1 (1 %)
0
 Incus
75 (89 %)
9 (11 %)
0
 Stapes
27 (32 %)
42 (50 %)
13 (15 %)
Facial nerve
Normal
Aberrant course
UTI
 Tympanic
54 (64 %)
24 (29 %)
6 (7 %)
 Mastoid
70 (83 %)
6 (7 %)
8 (10 %)
Vestibular aqueduct
Normal
Aberrant course
UTI
 
12 (14 %)
57 (68 %)
12 (14 %)
Cochlear apertura
Normal
Stenotic
UTI
 
51 (61 %)
31 (37 %)
2 (2, 4 %)
SCC
Normal
Aplastic
Dysplastic
 
2 (2 %)
65 (77 %)
17 (20 %)
Number of ears: 84
UTI unable to identify; PPS persistent petrosquamosal sinus, SCC semicircular canals
Table 3
Ear structure measurements
Structure
Mean (mm)
Median (mm)
SD (mm)
Max (mm)
Min (mm)
UTI (ears)
Mastoid
 AP-size
10.6
11.0
3.2
19.4
5.0
21
 LM-size
7.9
7.0
6.2
40.0
1.2
22
Vestibulum
 Length
4.7
4.7
1.0
9.0
2.9
0
 Width
2.3
2.3
0.6
5.0
1.0
1.0
VA diametera
 
0.7
0.6
0.3
1.9
0.1
11
IAC
 
3.6
3.5
0.9
7.0
2.0
0
Number of ears: 84
aonly digital scans (n = 58)
AP anterior-posterior, LM lateral-medial, VA vestibular aqueduct, IAC internal auditory canal, SD standard deviation, UTI unable to identify
Table 4
Mutations
Patient no.
Mutation
Mutation type
Blake/Verloes criteria
1
Nonsense
Truncating
Positive
2
Missense
Non-truncating
Negative
3
Nonsense
Truncating
Positive
4
Nonsense
Truncating
Positive
5
Splice-site
Non-truncating
Negative
6
Splice-site
Non-truncating
Positive
7
Nonsense
Truncating
Positive
8
Missense
Non-truncating
Positive
9
Splice-site
Non-truncating
Atypical
10
Splice-site
non-truncating
Atypical
11
Missense
Non-truncating
Atypical
12
No mutation
 
Atypical
13
Missense
Non-truncating
Negative
14
Frameshift
Truncating
Positive
15
Frameshift
Truncating
Positive
16
Nonsense
Truncating
Positive
17
Nonsense
Truncating
Positive
18
Missense
Non-truncating
Positive
19
Nonsense
Truncating
Positive
20
Frameshift
Truncating
Positive
21
Splice-site
Non-truncating
Negative
22
Nonsense
Truncating
Positive
23
Splice-site
Non-truncating
Positive
24
Nonsense
Truncating
positive
25
Frameshift
Truncating
Positive
26
Frameshift
Truncating
Positive
27
Frameshift
Truncating
Positive
28
Missense
Non-truncating
Positive
29
Frameshift
Truncating
Positive
30
UV missense
 
Atypical
31
Frameshift
Truncating
Partial
32
Nonsense
Truncating
Positive
33
Splice-site
Non-truncating
Positive
34
Missense
Non-truncating
Positive
35
Splice-site
Non-truncating
Atypical
36
Nonsense
Truncating
Positive
37
Nonsense
Truncating
Positive
38
Frameshift
Truncating
Positive
39
Nonsense
Truncating
Positive
40
Frameshift
Truncating
Positive
41
Nonsense
Truncating
Atypical
42
Deletion
Truncating
Positive
UV unknown variant
Table 5
Distribution of cochlear types for different types of mutations
Cochlear type
Normal
IPIIa
Hypoplasia type III
Hypoplasia type IV
Total
49 (61.2 %)
7 (8.3 %)
3 (3.8 %)
21 (26.3 %)
Truncating mutations
27 (33.8 %)
6 (7.5 %)
3 (3.8 %)
14 (17.5 %)
Non-truncating mutations
22 (27.5 %)
1 (1.3 %)
0
7 (8.8 %)
Number of ears: 80 (patients 12 and 30 excluded)
aIncomplete partition type II without enlarged vestibular aqueduct or dilated vestibulum; P = 0.194 (χ2)
Table 6
Distribution of semicircular canal malformations for different types of mutations
Defect
SCC normal
PSCC dysplasia
SSCC dysplasia
PSCC + LSCC dysplasia
SCCC + LSCCC dysplasia
All aplastic
All dysplastic
Total
2 (2.5 %)
4 (5.0 %)
5 (6.3 %)
1 (1.3 %)
2 (2.5 %)
63 (78.8 %)
3 (3.8 %)
Truncating
0
0
3 (3.8 %)
0
0
46 (57.5 %)
1 (1.3 %)
Non-truncating
2 (2.5 %)
4 (5.0 %)
2 (2.5 %)
1 (1.3 %)
2 (2.5 %)
17 (21.3 %)
2 (2.5 %)
Number of ears: 80 (patients 12 and 30 excluded); P = 0.004 (χ2)
SCC semicircular canals, PSCC posterior semicircular canal, SSCC superior semicircular canal, LSCC lateral semicircular canal
Table 7
Surgical challenges in cochlear implantation
Surgical step
Structure on CT
Anomaly
Surgical challenge
Mastoidectomy
Mastoid
Underdeveloped
Reduced access to the middle ear
Vascular structures
Large emissary vein
Unexpected bleeding
 
PSS
Bleeding, reduced mastoid size
Semicircular canals
Aplasia
Loss of landmark
Post. tympanotomy
Facial nerve
More medial route
Facilitates entrance to the middle ear
Cochleostomy
Ossicles
Dysplasia
Obstructed vision by the incus
Facial nerve
Aberrant route
Impedes cochleostomy
Windows
Round window stenosis
Choosing optimal side for cochleostomy
Jugular bulb
High
Preparing cochleostomy
Insertion
Cochlea
Aplasia
Insertion
Post. posterior, PSS petrosquamosal sinus
Table 8
Combinations of anomalies often seen
Anomaly
In combination with
Number of patients (percentage of all patients)
Absent RW
Absent OW
12 (14.3 %)
Stenotic OW
Dysplastic stapes
23 (27.3 %)
Aberrant tympanic portion facial nerve
Dysplastic stapes
24 (28.6 %)
Total SCC hypoplasia
OW stenosis
21 (25.0 %)
Aberrant VA
SCC hypoplasia with SCA
14 (16.7 %)
SCC hypoplasia without SCA
14 (16.7 %)
OW oval window, RW round window, SCC semicircular canals, SCA stenotic cochlear aperture, VA vestibular aqueduct
The patients were investigated in different time periods and in different Dutch hospitals, so the scans were made with different scanner types and variable scan parameters.
We evaluated CTs of 84 ears of 42 patients (22 male, 20 female) with CHARGE syndrome (29 digital and 13 analogue scans). The scans were performed between 1996– 2010. The mean age of the patients at the time of scanning was 6.4 years, median 2.5 years (SD 9.8; min 0, max 47 years).

Imaging analysis

All imaging studies were evaluated by four observers (two head-and-neck radiologists with 13 and 7 years of experience and two otorhinolaryngologists with 10 and 15 years of experience), who then met to reach a consensus opinion. The reviewers had no access to patients’ names or their clinical information. Each ear was evaluated separately, in axial and coronal planes, if available. The anatomic structures and normative measures determined are presented in Table 9 in “Appendix” and Fig. 1.
Table 9
Radiologic criteria for the os petrosum in patients with CHARGE syndrome
Mastoid and vascular structures
 Mastoid
Observation: pneumatisation of one or more cells
Measurement: AP size: minimal distance from external meatus wall to sigmoid sinus taken at the middle of the meatus in the axial plane
Measurement: LM size: minimal distance from cortex to sinus at the most anterior border of the sinus perpendicular to the mastoid AP size
 Emissary veins
Observation: emissary veins through temporal squama, persistent petro-squamosal sinus [13]
Measurement: >1 and <1 mm
 Jugular bulb
Observation: high if at the level or cranial of the round window in axial plane
Middle ear
 Ossicles
Observation: dysplasia
 Windows
Observation: stenotic
 Facial nerve
Observation: normal with present SCC: in transverse plane caudal of the LSCC and lateral and superior of the oval window. In coronal plane lateral and medial of the SCC
Normal with absent SCC: coronal plane cranial of the oval window, posterior of the axis of the basal turn of the cochlea at the level of the anterior rim of the round window
Cochlear vestibular system
 Cochlea
Measurement: angle basal turn and midline skull (54.6 degrees (range 46.8°–63.8°; standard deviation, 3.5) [24]
Observation: dysplasia [31] with separate judgment of modiolus.
 SCC
Absent, dysplastic, normal
 Vestibulum
Measurement length: maximum longitudinal extension, width maximum transversal diameter, perpendicular to the length [22]. (normal (6.18–6.42) × (3.44–3.59) mm, interval)
 Vestibular aqueduct
Measurement: diameter at midpoint (normal 1.5–2 mm)
Observation: course
 IAC
Measurement: Midline in axial plane(normal 2–8 mm)
 Cochlear aperture
Observation: present or bony stenosis
 Nerves in IAC
Observation on MRI: normal, hypoplastic or aplastic
AP anterior-posterior, LM lateral-medial, SCC semicircular canal, LSCC lateral semicircular canal, IAC internal auditory canal
All the scans were analysed as extensively as possible, using a standardized form (Table 10 in “Appendix”) compiled specifically for this study. Items that could not be analysed, e.g. due to a missing coronal plane or to slice thickness, were scored as ‘unable to identify’ (UTI).
Table 10
Radiologic set of criteria for CT scan
https://static-content.springer.com/image/art%3A10.1007%2Fs00405-016-4141-z/MediaObjects/405_2016_4141_Tab10a_HTML.gif
https://static-content.springer.com/image/art%3A10.1007%2Fs00405-016-4141-z/MediaObjects/405_2016_4141_Tab10b_HTML.gif
https://static-content.springer.com/image/art%3A10.1007%2Fs00405-016-4141-z/MediaObjects/405_2016_4141_Tab10c_HTML.gif
https://static-content.springer.com/image/art%3A10.1007%2Fs00405-016-4141-z/MediaObjects/405_2016_4141_Tab10d_HTML.gif
https://static-content.springer.com/image/art%3A10.1007%2Fs00405-016-4141-z/MediaObjects/405_2016_4141_Tab10e_HTML.gif
PSCC posterior semicircular canal, SSCC superior semicircular canal, LSCC lateral semicircular canal, SCC semicircular canal, AP anterior-posterior, LM lateral-medial
The digital scans were analysed on a viewing station (IMPAX, Apache Software Foundation, Version 2.0, January 2004). Measurements were obtained in millimetre (to two decimal places) with electronic calipers provided by the pacs-system. Analogue films were evaluated on an illuminated view box and measurements were performed with an analogue ruler. If a structure could not be properly assessed, it was scored as ‘unable to identify’ (UTI).
SPSS 20 was used to collect all data and perform statistical analyses. We used the χ 2 test to test for significant correlations.

CHD7 analysis

The results of CHD7 analysis were already known for all but one (patient 12) patient. The analyses were performed on DNA isolated from peripheral blood cells according to standard procedures. The 37 coding exons of CHD7 (exons 2–38, RefSeq NM_017780.02) and their flanking intron sequences were amplified by PCR and sequenced as described earlier [3]. If no mutations were identified, CHD7 was screened for whole exon deletions and duplications by multiplex ligation-dependent probe amplification (MLPA) using a commercially available set of probes: the SALSA P201 kit (MRC-Holland, Amsterdam, the Netherlands; http://​www.​mrc-holland.​com) [6].
Nonsense and frameshift mutations and whole-gene or whole-exome deletions were categorised as truncating mutations, while missense and splice site mutations were categorised as non-truncating.

Results

Mastoid and vascular structures (Tables 2, 3)

The first part of a cochlear implantation, the mastoidectomy, can be challenging in an underdeveloped mastoid. The AP-size (anterior-posterior) and the LM-size (lateral-medial) of the mastoid could not be measured in 21 ears (25 %), because of a hardly developed mastoid or moderate quality of the scan. These patients were particularly young (median age 5 years, mean 8.5 years, 22 % <1-year-old). In 25 ears (29.8 %), an emissary vein with a diameter larger than 1 mm was present (Fig. 2a, b).

Middle ear (windows/ossicles/facial nerve) (Tables 2, 3)

Middle ear anomalies can be a challenge in preparing and making the cochleostomy. The size of the middle ear cavity was within normal limits in all patients and thus will not pose a problem in surgery. Overall, there was an aberrant course of the tympanic part of the facial nerve crossing the promontory in 16 ears (19.0 % of the total number of ears) and in eight ears also the round window (9.5 % of the total number of ears). The aberrant mastoidal portion of the facial nerve seemed to run more medially than normal in four ears. The windows and ossicles were difficult to assess due either to otitis media or to the moderate quality of the scan in 20 patients (23.8 %).
In 43 ears (51.2 %) with a stenotic oval window, the stapes was not identifiable or dysplastic, either presenting as a monopod stapes (one ear), or displaced on the promontory or into the middle ear cavity (six ears) (Fig. 3).

Cochleovestibular system (Tables 5, 6)

Abnormalities of the cochlea can complicate the insertion of the electrode array. Table 5 shows the distribution of cochlear type, omitting patient 12 (who had no mutation found and normal cochleas), and patient 30 (who had a UV missense mutation, one normal cochlea and one cochlear hypoplasia type IV). In 32 (38.1 %) ears, an abnormal cochlea was seen. The ears with an incomplete partition type II (IPII) deformity of the cochlea did not show an enlarged vestibular aqueduct or dilated vestibulum. In 22 (26.2 %) ears, the cochlea appeared abnormal, but the type of dysplasia could not be determined according to Sennaroglu’s classification (Fig. 4a–c). In these cochleae, the second turn seemed not to have developed fully, but the apex and basal turn were normal, with normal presence of interscalar septae and spiral osseous lamina, and in all but two of them the modiolus was normal. We will refer to this as hypoplasia type IV.
The angle of the basal turn was only measured on the digital scans; the mean was 57° (SD 6.3), with a range from 43.5° to 78.6°. The mean age of this group was 3.7 years.
Table 6 shows the distribution of SCC malformations excluding patient 12 (no mutation found and dysplasia of LSCC bilaterally) and patient 30 (UV missense mutation and total aplasia of SCC bilaterally). Aplasia of all SCCs was seen in 65 ears (77.3 %), while dysplasia of one or all SCCs was seen in 17 ears (20.2 %) and ranged from the strongly reduced development of one canal, like a bud, to just one affected canal (while the other two were present and normal) (Fig. 5a, b). In ears with a solitary canal aplasia or dysplasia, it was the lateral semicircular canal that was most often affected. If the superior semicircular canal was dysplastic, the lateral and posterior semicircular canals were absent.
Generally, the vestibulum was smaller than normal, both in length and width. The aberrant vestibular aqueducts had a course mainly in a perpendicular line from the vestibulum to the posterior fossa. If SCCs were absent, the aqueduct showed a more medial course than when they were severe or mild dysplastic. We found one ear with a large vestibular aqueduct (1.9 mm diameter), but normally developed cochlea.

Cochlear aperture and inner ear (Table 2)

In 13 of 31 ears with a stenotic aperture, the cochlea was abnormal (one incomplete partitioning type II, three hypoplasia type III, and nine type IV) (Table 2; Fig. 6).

Surgical challenges

Table 7 summarizes the observed anomalies expecting to be challenging in cochlear implant surgery. Figure 7 illustrates the differences in mastoid size between an ear with a small mastoid and an ear with a wide mastoid (AP-size).

Phenotypes

No typical CHARGE phenotype of the temporal bone, i.e. a constant combination of several anomalies, could be determined. Some combinations of anomalies which were often seen are presented in Table 8. More than two-thirds of the patients (68 %) had an aberrant course of the vestibular aqueduct, and more than two-thirds (77 %) had aplasia of the SCC.

Genotypes (Table 4)

The results of CHD7 analysis were available for all 42 patients. We had 25 patients (50 ears, 59.5 % of 84 ears) with a truncating mutation (of which were 56 % nonsense, 20 % frameshift, 4 % deletions) and 15 patients (30 ears, 35.7 % of 84 ears) with a non-truncating mutation (47 % missense, 53 % splice site). In one patient an unclassified CHD7 variant was detected (UV-missense) and in another patient no CHD7 mutation was found. Remarkably, 12/42 patients did not fully comply with the clinical diagnostic criteria [2]. Of these 12 patients, eight had a non-truncating mutation, in one patient no mutation was found, and in another only an unclassified variant could be detected in CHD7. Thus, only 2/12 atypical patients (16.7 %) had a truncating mutation. In contrast, truncating mutations were found in 23/30 patients (76.7 %) who had clinically typical CHARGE syndrome.
Because no constant combination of anomalies could be identified, no correlation could be made between phenotype and genotype. Nevertheless, of the surgical challenging anomalies, SCC aplasia (Table 6) and oval window atresia (truncating 72 %, P = 0.001) were found more frequently in patients with truncating mutations than in those with non-truncating mutations (P < 0.05) (Chi-squared test). Cochlear anomalies (Table 5), petrosquamosal sinus (73 % truncating, P = 0.679) and an aberrant course of the tympanic portion of the facial nerve (67 % truncating, P = 0.602) were also found more frequently in patients with truncating mutations than in those with non-truncating mutations, but these results were not significant (Chi-squared test).
The patient without anomalies of the SCC, cochlea and windows, had a non-truncating mutation. In contrast, in the group with truncating mutations, there were no patients without anomalies of at least one of these structures.

Discussion

Analysis of the available imaging material and genetic information of the Dutch cohort of patients with CHARGE syndrome revealed a great variability in anomalies of the temporal bone with possible implications for cochlear implantation. More anomalies were found in patients with truncating CHD7 mutations than in those with non-truncating mutations. A shortcoming of this study is the variability in image quality leading to missing values of several fine anatomical structures (the imaging data were collected from different hospitals). Nevertheless, we were able to analyse the temporal bone and the anomalies, and to assess the potential impact on plans for cochlear implant surgery.
Temporal bone anomalies detected by CT are important when planning an operation. Vascular variations, missing anatomical landmarks such as the lateral semicircular canal or the vestibular system, an aberrant course of the facial nerve, or stenosis of the round window may hamper safe surgical access to the round window. Given our findings, when planning CI or ear surgery, care must be taken with regard to the reduced development of the mastoid, leading to a smaller access to the middle ear, especially in young children. In these cases, an endaural approach instead of a mastoidectomy [7], or a temporary intra-operative removal or anterior displacement of the posterior wall of the outer ear canal could be considered. Vascular anomalies could also complicate a mastoidectomy, since these may cause uncontrollable bleeding during surgery or postoperative thrombosis of the sigmoid sinus [810]. In our group of CHARGE patients, large emissary veins and a persistent petrosquamosal sinus were often present. Whereas emissary veins through the temporal squama are a common anatomical variant [11, 12] and easily dealt with during surgery, a persistent petrosquamosal sinus is rare in the general population (Koesling et al. [11] estimated this at 1 %). However, several authors have reported it to be present in 11–89 % of CHARGE patients [9, 1315]. The highest incidence was described by Giesemann et al. [14], in patients who all had aplasia of the SCCs. In our patient population, which included patients with partially and fully developed vestibular systems, a persistent petrosquamosal sinus was seen in 13 %. The persistent petrosquamosal sinus can impede the surgical approach, this can be a reason to choose the contra lateral ear for CI.
SCC aplasia is a hallmark of CHARGE syndrome. CHD7 is highly expressed in the developing ear and is required for development of the SCCs. Delayed fusion and altered gene expression contribute to SCC defects in CHD7-deficient mice [16]. Currently, the presence of SCC abnormalities is considered an important indication for performing sequencing of the CHD7 gene and diagnosis [17]. In our study, we found that normal SCC were present in only one patient. However, during mastoidectomy, the lateral SCC serves as an important anatomical landmark, so the appearance of the SCCs, ranging from complete absence of all canals to normal development, should be meticulously described [7, 13]. In case of a lateral SCC aplasia, the tegmen serves as a paramount marker to direct the surgeon towards the antrum. Anomalies of the SCCs were associated with hypoplasia of the vestibule and a shortened vestibular aqueduct coursing straight to the posterior fossa. This confirms what was reported by Morimoto et al.: ‘An aberrant course of the vestibular aqueduct is hypothesized to be the result of semicircular aplasia and the associated displacement of normal surrounding structures’ [9].
The facial nerve is another structure at risk during cochlear implantation. As described in the literature, the facial nerve often showed an aberrant course in its tympanic or mastoidal portion [9, 13, 18]. The more medial course of the mastoidal portion of the facial nerve allows a surgeon to create a wider entrance to the middle ear (through a posterior tympanotomy). However, the aberrant course of the tympanic segment of the facial nerve, in particular when it covers the round window, may complicate creating the cochleostomy for intracochlear insertion of the cochlear implant. The aberrant facial nerve may be at risk of injury during cochleostomy [19] or may even be a reason to abort the implantation [20]. The association we observed of an aberrant course of the facial nerve with dysplastic stapes and absence of the oval window was described by Zeifer et al. in different aetiologies without CHARGE syndrome [21].
Absence or stenosis of the oval window was present in more than two-thirds of our patients and is a well-known feature in CHARGE syndrome [9, 13, 22, 23]. Stenosis or absence of the round window was seen less often (as confirmed in the literature). Yet this poses an additional challenge for the surgeon in choosing the optimal site for a cochleostomy.
The size and shape of the cochlea will influence the choice of CI-type. According to the literature, the cochlea is dysplastic in between 20 and 100 % of the ears described in patients with CHARGE syndrome [9, 18, 24, 25]. The anomalies vary from a fused second and apical turn to a cochlea with 1.5 turns [2628]. We describe several cases with a shortened cochlea despite the presence of a basal, second and apical turn (referred to as hypoplasia type IV). To the best of our knowledge, this cochlear appearance has not been described in CHARGE syndrome before, but it appears to be consistent with the description of cochlear hypoplasia type IV in a recently published study by Sennaroglu [29] or may be comparable with the flattened cochlea observed by Elmaleh et al. [30] in patients with Waardenburg syndrome. However, the other temporal bone anomalies described in Waardenburg syndrome, besides SCC aplasia and the flattened cochlea, differ from our findings.
Both this cochlear anomaly, as well as the IPII and hypoplasia type III found in this study, should not cause any problems for the insertion of an electrode array as opposed to more severe malformations [31, 32]. The successful outcome of a cochlear implantation also depends on the presence of the cochleo-vestibular nerve.
In our phenotype-genotype analysis we showed that total aplasia of the SCC and oval window aplasia is more common in patients with truncating mutations than in those with non-truncating mutations—in agreement with the results of Corsten-Janssen et al. showing more anomalies in patients with truncating mutations [33]. Remarkably, the distribution of mutations present in our cohort differs from that reported for large cohorts in the literature. Our percentage of patients with non-truncating mutations (splice-site and missense) was relatively high with 35.7 % in comparison to Zentner et al. [5] and to Janssen et al. [4] who reported 23 and 20 % of patients with non-truncating mutations, respectively. This discrepancy might be because a CT is often used in mildly affected patients to check the semicircular canals and to provide further proof for the clinical diagnosis. Our cohort might be enriched with more mildly affected patients (12/42), and thus of missense mutations.
In general, we conclude that temporal bone findings in patients with CHARGE syndrome vary widely and should therefore be studied meticulously before performing any surgery. Imaging may exclude patients from cochlear implantation or reveal an aberrant course of the facial nerve, vascular and middle ear abnormalities that could complicate CI surgery. Such information is valuable and should be combined with records on the developmental and behavioural problems that are also common in CHARGE syndrome. Moreover, patients with CHARGE syndrome often have post-surgical complications due to their neurological and anatomical abnormalities [34]. A balance between the benefit of CI, the surgical procedure’s chance of success, and the anaesthetic risks should be sought by a multi-disciplinary team working with the patient and his/her family.

Acknowledgments

We thank parents of patients for giving the permission to use their data. We thank Jackie Senior for editing the manuscript. This study was funded by Cochlear BV.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med HNO

Kombi-Abonnement

Mit e.Med HNO erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes HNO, den Premium-Inhalten der HNO-Fachzeitschriften, inklusive einer gedruckten HNO-Zeitschrift Ihrer Wahl.

Anhänge

Appendix

See Tables 9 and 10.
Literatur
1.
Zurück zum Zitat Blake KD, Davenport SL, Hall BD et al (1998) CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) 37:159–173CrossRef Blake KD, Davenport SL, Hall BD et al (1998) CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) 37:159–173CrossRef
2.
Zurück zum Zitat Verloes A (2005) Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A 133A:306–308CrossRefPubMed Verloes A (2005) Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A 133A:306–308CrossRefPubMed
3.
Zurück zum Zitat Jongmans MC, Admiraal RJ, van der Donk KP et al (2006) CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet 43:306–314CrossRefPubMed Jongmans MC, Admiraal RJ, van der Donk KP et al (2006) CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet 43:306–314CrossRefPubMed
4.
Zurück zum Zitat Janssen N, Bergman JE, Swertz MA et al (2012) Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat 33:1149–1160CrossRefPubMed Janssen N, Bergman JE, Swertz MA et al (2012) Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat 33:1149–1160CrossRefPubMed
5.
Zurück zum Zitat Zentner GE, Layman WS, Martin DM, Scacheri PC (2010) Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A 152A:674–686CrossRefPubMedPubMedCentral Zentner GE, Layman WS, Martin DM, Scacheri PC (2010) Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A 152A:674–686CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bergman JE, de Wijs I, Jongmans MC, Admiraal RJ, Hoefsloot LH, van Ravenswaaij-Arts CM (2008) Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome. Eur J Med Genet 51:417–425CrossRefPubMed Bergman JE, de Wijs I, Jongmans MC, Admiraal RJ, Hoefsloot LH, van Ravenswaaij-Arts CM (2008) Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome. Eur J Med Genet 51:417–425CrossRefPubMed
7.
Zurück zum Zitat Stjernholm C (2003) Aspects of temporal bone anatomy and pathology in conjunction with cochlear implant surgery. Acta Radiol Suppl 430:2–15CrossRefPubMed Stjernholm C (2003) Aspects of temporal bone anatomy and pathology in conjunction with cochlear implant surgery. Acta Radiol Suppl 430:2–15CrossRefPubMed
8.
Zurück zum Zitat Marsot-Dupuch K, Gayet-Delacroix M, Elmaleh-Berges M, Bonneville F, Lasjaunias P (2001) The petrosquamosal sinus: CT and MR findings of a rare emissary vein. AJNR Am J Neuroradiol 22:1186–1193PubMed Marsot-Dupuch K, Gayet-Delacroix M, Elmaleh-Berges M, Bonneville F, Lasjaunias P (2001) The petrosquamosal sinus: CT and MR findings of a rare emissary vein. AJNR Am J Neuroradiol 22:1186–1193PubMed
9.
Zurück zum Zitat Morimoto AK, Wiggins RH 3rd, Hudgins PA et al (2006) Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings. AJNR Am J Neuroradiol 27:1663–1671PubMed Morimoto AK, Wiggins RH 3rd, Hudgins PA et al (2006) Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings. AJNR Am J Neuroradiol 27:1663–1671PubMed
10.
Zurück zum Zitat An YH, Wee JH, Han KH, Kim YH (2011) Two cases of petrosquamosal sinus in the temporal bone presented as perioperative finding. Laryngoscope 121:381–384CrossRefPubMed An YH, Wee JH, Han KH, Kim YH (2011) Two cases of petrosquamosal sinus in the temporal bone presented as perioperative finding. Laryngoscope 121:381–384CrossRefPubMed
11.
Zurück zum Zitat Koesling S, Kunkel P, Schul T (2005) Vascular anomalies, sutures and small canals of the temporal bone on axial CT. Eur J Radiol 54:335–343CrossRefPubMed Koesling S, Kunkel P, Schul T (2005) Vascular anomalies, sutures and small canals of the temporal bone on axial CT. Eur J Radiol 54:335–343CrossRefPubMed
12.
Zurück zum Zitat Louis RG Jr, Loukas M, Wartmann CT et al (2009) Clinical anatomy of the mastoid and occipital emissary veins in a large series. Surg Radiol Anat 31:139–144CrossRefPubMed Louis RG Jr, Loukas M, Wartmann CT et al (2009) Clinical anatomy of the mastoid and occipital emissary veins in a large series. Surg Radiol Anat 31:139–144CrossRefPubMed
13.
Zurück zum Zitat Satar B, Mukherji SK, Telian SA (2003) Congenital aplasia of the semicircular canals. Otol Neurotol 24:437–446CrossRefPubMed Satar B, Mukherji SK, Telian SA (2003) Congenital aplasia of the semicircular canals. Otol Neurotol 24:437–446CrossRefPubMed
14.
Zurück zum Zitat Giesemann AM, Goetz GF, Neuburger J, Lenarz T, Lanfermann H (2011) Persistent petrosquamosal sinus: high incidence in cases of complete aplasia of the semicircular canals. Radiology 259:825–833CrossRefPubMed Giesemann AM, Goetz GF, Neuburger J, Lenarz T, Lanfermann H (2011) Persistent petrosquamosal sinus: high incidence in cases of complete aplasia of the semicircular canals. Radiology 259:825–833CrossRefPubMed
15.
Zurück zum Zitat Friedmann DR, Amoils M, Germiller JA et al (2012) Venous malformations of the temporal bone are a common feature in CHARGE syndrome. Laryngoscope 122:895–900CrossRefPubMed Friedmann DR, Amoils M, Germiller JA et al (2012) Venous malformations of the temporal bone are a common feature in CHARGE syndrome. Laryngoscope 122:895–900CrossRefPubMed
16.
Zurück zum Zitat Hurd EA, Micucci JA, Reamer EN, Martin DM (2012) Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev 129:308–323CrossRefPubMedPubMedCentral Hurd EA, Micucci JA, Reamer EN, Martin DM (2012) Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev 129:308–323CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM (2011) CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet 48:334–342CrossRefPubMed Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM (2011) CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet 48:334–342CrossRefPubMed
18.
Zurück zum Zitat Lanson BG, Green JE, Roland JT Jr, Lalwani AK, Waltzman SB (2007) Cochlear implantation in Children with CHARGE syndrome: therapeutic decisions and outcomes. Laryngoscope 117:1260–1266CrossRefPubMed Lanson BG, Green JE, Roland JT Jr, Lalwani AK, Waltzman SB (2007) Cochlear implantation in Children with CHARGE syndrome: therapeutic decisions and outcomes. Laryngoscope 117:1260–1266CrossRefPubMed
19.
Zurück zum Zitat Ahn JH, Lee KS (2013) Outcomes of cochlear implantation in children with CHARGE syndrome. Acta Otolaryngol 133:1148–1153CrossRefPubMed Ahn JH, Lee KS (2013) Outcomes of cochlear implantation in children with CHARGE syndrome. Acta Otolaryngol 133:1148–1153CrossRefPubMed
20.
Zurück zum Zitat Bauer PW, Wippold FJ 2nd, Goldin J, Lusk RP (2002) Cochlear implantation in children with CHARGE association. Arch Otolaryngol Head Neck Surg 128:1013–1017CrossRefPubMed Bauer PW, Wippold FJ 2nd, Goldin J, Lusk RP (2002) Cochlear implantation in children with CHARGE association. Arch Otolaryngol Head Neck Surg 128:1013–1017CrossRefPubMed
21.
Zurück zum Zitat Zeifer B, Sabini P, Sonne J (2000) Congenital absence of the oval window: radiologic diagnosis and associated anomalies. AJNR Am J Neuroradiol 21:322–327PubMed Zeifer B, Sabini P, Sonne J (2000) Congenital absence of the oval window: radiologic diagnosis and associated anomalies. AJNR Am J Neuroradiol 21:322–327PubMed
22.
Zurück zum Zitat Admiraal RJ, Joosten FB, Huygen PL (1998) Temporal bone CT findings in the CHARGE association. Int J Pediatr Otorhinolaryngol 45:151–162CrossRefPubMed Admiraal RJ, Joosten FB, Huygen PL (1998) Temporal bone CT findings in the CHARGE association. Int J Pediatr Otorhinolaryngol 45:151–162CrossRefPubMed
23.
Zurück zum Zitat Arndt S, Beck R, Schild C, Grauvogel TD, Laszig R, Aschendorff A (2010) Management of cochlear implantation in patients with malformations. Clin Otolaryngol 35:220–227CrossRefPubMed Arndt S, Beck R, Schild C, Grauvogel TD, Laszig R, Aschendorff A (2010) Management of cochlear implantation in patients with malformations. Clin Otolaryngol 35:220–227CrossRefPubMed
24.
Zurück zum Zitat Holcomb MA, Rumboldt Z, White DR (2013) Cochlear nerve deficiency in children with CHARGE syndrome. Laryngoscope 123:793–796CrossRefPubMed Holcomb MA, Rumboldt Z, White DR (2013) Cochlear nerve deficiency in children with CHARGE syndrome. Laryngoscope 123:793–796CrossRefPubMed
25.
Zurück zum Zitat Song MH, Cho HJ, Lee HK et al (2011) CHD7 mutational analysis and clinical considerations for auditory rehabilitation in deaf patients with CHARGE syndrome. PLoS One 6:e24511CrossRefPubMedPubMedCentral Song MH, Cho HJ, Lee HK et al (2011) CHD7 mutational analysis and clinical considerations for auditory rehabilitation in deaf patients with CHARGE syndrome. PLoS One 6:e24511CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Guyot JP, Gacek RR, DiRaddo P (1987) The temporal bone anomaly in CHARGE association. Arch Otolaryngol Head Neck Surg 113:321–324CrossRefPubMed Guyot JP, Gacek RR, DiRaddo P (1987) The temporal bone anomaly in CHARGE association. Arch Otolaryngol Head Neck Surg 113:321–324CrossRefPubMed
27.
Zurück zum Zitat Glueckert R, Rask-Andersen H, Sergi C et al (2010) Histology and synchrotron radiation-based microtomography of the inner ear in a molecularly confirmed case of CHARGE syndrome. Am J Med Genet A 152A:665–673CrossRefPubMed Glueckert R, Rask-Andersen H, Sergi C et al (2010) Histology and synchrotron radiation-based microtomography of the inner ear in a molecularly confirmed case of CHARGE syndrome. Am J Med Genet A 152A:665–673CrossRefPubMed
28.
Zurück zum Zitat Haginomori S, Sando I, Miura M, Casselbrant ML (2002) Temporal bone histopathology in CHARGE association. Ann Otol Rhinol Laryngol 111:397–401CrossRefPubMed Haginomori S, Sando I, Miura M, Casselbrant ML (2002) Temporal bone histopathology in CHARGE association. Ann Otol Rhinol Laryngol 111:397–401CrossRefPubMed
29.
Zurück zum Zitat Sennaroglu L, Yucel E, Sennaroglu G, Ozgen B (2015) Management of Children with Inner Ear Malformations. In: Publishers JM, (ed.) Sataloff’s comprehensive textbook of otolaryngology: head and neck surgery (pediatric otolaryngology), p 91–106 Sennaroglu L, Yucel E, Sennaroglu G, Ozgen B (2015) Management of Children with Inner Ear Malformations. In: Publishers JM, (ed.) Sataloff’s comprehensive textbook of otolaryngology: head and neck surgery (pediatric otolaryngology), p 91–106
30.
Zurück zum Zitat Elmaleh-Berges M, Baumann C, Noel-Petroff N et al (2013) Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations. AJNR Am J Neuroradiol 34:1257–1263CrossRefPubMed Elmaleh-Berges M, Baumann C, Noel-Petroff N et al (2013) Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations. AJNR Am J Neuroradiol 34:1257–1263CrossRefPubMed
31.
Zurück zum Zitat Mylanus EA, Rotteveel LJ, Leeuw RL (2004) Congenital malformation of the inner ear and pediatric cochlear implantation. Otol Neurotol 25:308–317CrossRefPubMed Mylanus EA, Rotteveel LJ, Leeuw RL (2004) Congenital malformation of the inner ear and pediatric cochlear implantation. Otol Neurotol 25:308–317CrossRefPubMed
32.
Zurück zum Zitat Sennaroglu L (2010) Cochlear implantation in inner ear malformations–a review article. Cochlear Implants Int 11:4–41CrossRefPubMed Sennaroglu L (2010) Cochlear implantation in inner ear malformations–a review article. Cochlear Implants Int 11:4–41CrossRefPubMed
33.
Zurück zum Zitat Bergman JE, Janssen N, van der Sloot AM et al (2012) A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome. Hum Mutat 33:1251–1260CrossRefPubMed Bergman JE, Janssen N, van der Sloot AM et al (2012) A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome. Hum Mutat 33:1251–1260CrossRefPubMed
34.
Zurück zum Zitat Blake K, MacCuspie J, Hartshorne TS, Roy M, Davenport SL, Corsten G (2009) Postoperative airway events of individuals with CHARGE syndrome. Int J Pediatr Otorhinolaryngol 73:219–226CrossRefPubMed Blake K, MacCuspie J, Hartshorne TS, Roy M, Davenport SL, Corsten G (2009) Postoperative airway events of individuals with CHARGE syndrome. Int J Pediatr Otorhinolaryngol 73:219–226CrossRefPubMed
Metadaten
Titel
CT findings of the temporal bone in CHARGE syndrome: aspects of importance in cochlear implant surgery
verfasst von
A. C. Vesseur
B. M. Verbist
H. E. Westerlaan
F. J. J. Kloostra
R. J. C. Admiraal
C. M. A. van Ravenswaaij-Arts
R. H. Free
E. A. M. Mylanus
Publikationsdatum
20.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4141-z

Weitere Artikel der Ausgabe 12/2016

European Archives of Oto-Rhino-Laryngology 12/2016 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.